Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Gabapentin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced one-pot synthesis for 1-cyano-cyclohexyl acetonitrile. Enhances purity to 99.9% and reduces manufacturing costs for reliable pharmaceutical intermediate supply chains.
Patent CN104342463B reveals high-purity biocatalytic route. Enhances supply chain reliability and reduces manufacturing costs for gabapentin intermediates significantly for global buyers.
Patent CN105602922A reveals efficient amidase catalysis for gabapentin intermediates. Achieve high purity and cost reduction in pharmaceutical intermediates manufacturing with scalable biocatalytic routes.
Patent CN104402752A reveals high purity synthesis route. Offers significant cost reduction and supply chain reliability for global pharmaceutical intermediates manufacturing partners.
Patent CN1438985A details a stereoselective route to gabapentin analogs using chiral enones, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.